Internal Medicine, Hematology & Oncology · Cincinnati, OH
NPI
1194765800
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3301 Mercy Health Blvd Ste 100
Cincinnati, OH, 45211
Phone (513) 751-2273
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.4M
156,520 services
Medicare patients, 2024
729
Average age 74
Drug cost, 2024
$7.7M
3,475 prescriptions
Company payments, 2025
$3,101
From 33 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kurt P Leuenberger was code J9299 (injection, nivolumab, 1 mg), 24,160 times for 12 patients. In total Kurt P Leuenberger billed 156,520 services in 134 codes, and Medicare paid $3.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-07-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9299 Injection, nivolumab, 1 mg | Office | 24,160 | 12 | $24.59 | $594K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 14,400 | 14 | $44.67 | $643K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 5,700 | 13 | $0.11 | $623 |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 5,540 | 22 | $6.38 | $35K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 4,826 | 54 | $0.09 | $435 |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 1,800 | 17 | $15.76 | $28K |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 1,640 | 24 | $0.25 | $414 |
| J0897 Injection, denosumab, 1 mg | Office | 1,320 | 12 | $19.86 | $26K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 1,264 | 29 | $0.07 | $93.54 |
| 85025 Blood Count | Office | 1,250 | 398 | $7.58 | $9,479 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,130 | 23 | $0.74 | $833 |
| 99213 Office E&M - Established | Office | 723 | 439 | $59.11 | $43K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 693 | 414 | $11.86 | $8,219 |
| 80053 Clinical Chemistry | Office | 676 | 233 | $10.33 | $6,980 |
| 99214 Office E&M - Established | Office | 665 | 230 | $90.11 | $60K |
By year: 2022 $2.7M for 142,950 services; 2023 $3.4M for 170,580 services; 2024 $3.4M for 156,520 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,250 | 398 | $7.58 | $9,479 |
| 80053 Clinical Chemistry | 676 | 233 | $10.33 | $6,980 |
| 84443 Clinical Chemistry | 157 | 48 | $16.46 | $2,584 |
| 82728 Clinical Chemistry | 132 | 84 | $13.36 | $1,764 |
| 83540 Clinical Chemistry | 117 | 81 | $6.34 | $742 |
| 83550 Clinical Chemistry | 117 | 81 | $8.57 | $1,003 |
| 82378 Clinical Chemistry | 62 | 31 | $18.58 | $1,152 |
| 84153 Clinical Chemistry | 55 | 22 | $18.02 | $991 |
| 82607 Clinical Chemistry | 40 | 39 | $14.78 | $591 |
| 82746 Clinical Chemistry | 23 | 23 | $14.41 | $331 |
Medicare prescription drug claims, 2024
In 2024, the drug Kurt P Leuenberger prescribed most often to Medicare patients was Eliquis (Apixaban), with 303 prescriptions and refills. In total Kurt P Leuenberger wrote 3,475 Medicare prescriptions that cost $7.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 303 | 421 | 65 | $241K |
| Oxycodone Hcl Generic | 277 | 277 | 48 | $5,420 |
| Prednisone Generic | 196 | 200 | 65 | $645 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 144 | 144 | 20 | $6,086 |
| Anastrozole Generic | 143 | 343 | 34 | $2,329 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 137 | 137 | 27 | $2,462 |
| Xarelto Rivaroxaban | 134 | 216 | 27 | $116K |
| Gabapentin Generic | 119 | 161 | 23 | $1,257 |
| Morphine Sulfate Er Morphine Sulfate | 115 | 115 | 29 | $2,831 |
| Imbruvica Ibrutinib | 83 | 83 | Under 11 | $1.2M |
| Potassium Chloride Generic | 83 | 161 | 22 | $984 |
| Dexamethasone Generic | 74 | 76 | 21 | $1,003 |
| Revlimid Lenalidomide | 58 | 58 | Under 11 | $977K |
| Lenalidomide Generic | 47 | 47 | Under 11 | $687K |
| Azithromycin Generic | 46 | 46 | 36 | $148 |
Brand drugs: - claims; generic drugs: 2,578 claims; opioid claims: 724.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kurt P Leuenberger $3,101 ($3,101 in general payments such as food, travel and fees) from 33 companies. The largest payer was Avyxa Pharma, LLC with $1,000.
| Company | Payments | Amount |
|---|---|---|
| Avyxa Pharma, LLC | 1 | $1,000 |
| Abbvie Inc. ABBV | 8 | $203 |
| Novartis Pharmaceuticals Corporation NVS | 15 | $186 |
| Genentech USA, Inc. ROG.SW | 10 | $186 |
| Janssen Biotech, Inc. JNJ | 5 | $174 |
| Pfizer Inc. PFE | 7 | $105 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $95.18 |
| Merck Sharp & Dohme LLC MRK | 4 | $93.75 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $90.79 |
| Sobi, Inc SOBI.ST | 1 | $89.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.